ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Effects of Immunosuppressives On Porcine Renal Microvascular Endothelial Cell–Activated Human T Cell Proliferation: A Cellular Model of Kidney Xenotransplantation In Vitro

    Z.-Y. Wang, M. Tector, S. Nagai, J. Butler, R. Blankenship, S. Downey, J. Estrada, P. Li, A. Tector.

    Surgery, Indiana University School of Medicine, Indianapolis, IN.

    Background: The creation of genetically-modified pigs has brought us closer than ever to clinical xenotransplantation. However, the optimal immunosuppressive doses still need to be established…
  • 2015 American Transplant Congress

    Presence of Donor Leukocytes and Donor MHC-Cross-Dressed Recipient Cells and Its Relationship to Direct T Cell Alloresponses After Allotransplantation

    J. Marino,1 P. Crosby Bertorini,1 M. Uehara,2 J. Paster,1 S. Mordecai,3 W.-H. Liu,1 L. Liu,1 R. Abdi,2 G. Tocco,1 J. Kim,1 J. Markmann,1 G. Benichou.1

    1Surgery Department, Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, MA; 2Department of Medicine, Renal Division, Brigham and Women's Hospital, Boston, MA; 3Department of Pathology, Flow and Imaging Cytometry Core, Massachusetts General Hospital, Boston, MA.

    We have studied the kinetics of donor cell trafficking from the graft to recipient's lymphoid organs and its correlation to the direct T cell alloresponse…
  • 2015 American Transplant Congress

    mTOR Inhibitors Reduce the Endothelial Transmigration of Leukocytes After Ischemia

    I. Werner, A. Hernandez-Sierra, F. Guo, A. Moritz, A. Beiras-Fernandez.

    Department of Thoracic and Cardiovascular Surgery, University Hospital Frankfurt, Frankfurt am Main, Germany.

    ObjectivemTOR inhibitors Everolimus and Sirolimus are currently used as maintenance immunosuppressive agents to prevent rejection of solid transplanted organs. Episodes of transplant rejection and graft…
  • 2015 American Transplant Congress

    Local Expansion in DCD Kidney Transplant Activity Improves Waiting List Outcomes and Addresses Inequities of Access to Transplantation

    B. Mirshekar-Syahkal,1 L. Bradbury,2 P. Sun,1 M. Aly,1 M. Berry,1 J. Norris,1 J. Bradley,1 G. Pettigrew.1

    1Cambridge University, Cambridge, United Kingdom; 2NHSBT, Bristol, United Kingdom.

    Introduction: Following expansion in our circulatory death (DCD) transplant program, our center now performs twice as many DCD as brain-death (DBD) kidney transplants. Here, we…
  • 2015 American Transplant Congress

    Unknown Urological Pathologies in Renal Allografts from Deceased Donors. Should Image Evaluation Be Routinely Performed?

    K. Yamaçake, W. Nahas, I. Antonopoulos, H. Kanashiro, R. Kato, A. Bull, R. Falci, A. Piovesan.

    Division of Urology, Renal Transplantation Unit, University of Sao Paulo, Sao Paulo, Brazil.

    Purpose: In an effort to increase the overall donor pool, the use of extended-criteria kidneys has been routine in the majority of transplant centers. It…
  • 2015 American Transplant Congress

    Belatacept in a Community Hospital Adult Kidney Transplant Program

    D. Nikolaenko, Q. Chaudhry, H. Smith, C. Shadur.

    Iowa Methodist Medical Center, Des Moines, IA.

    PURPOSE:This is a retrospective look (08/2011-11/2014) on data collected from patients transplanted at Iowa Methodist Transplant Center.METHODS:All patients were EBV positive. They were induced with…
  • 2015 American Transplant Congress

    Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?

    K. Doucette, M. Charles, M. Al Dabbagh, J. Preiksaitis.

    Department of Medicine, University of Alberta, Edmonton, AB, Canada.

    Background: The most common pathogens seen in early post LT intraabdominal and bloodstream infection are enterococci, staphylococci and aerobic gram negative bacilli and perioperative prophylaxis…
  • 2015 American Transplant Congress

    Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation

    V. Fleetwood, J. Lusciks, M. Hertl, E. Chan.

    General Surgery, Division of Transplant Surgery, Rush University Medical Center, Chicago, IL.

    Introduction: An under-utilized demographic in liver transplantation is the CDC high-risk donor (HRD). These individuals, considered at higher risk of blood-borne diseases, contribute approximately 9%…
  • 2015 American Transplant Congress

    Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval

    Y. Nobel,1 D. Goldberg.2,3,4

    1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; 2Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; 3Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; 4Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.

    Purpose: Most patients with metastatic neuroendocrine tumors (NETs) have preserved hepatic synthetic function, and their providers may seek increased waitlist priority via MELD exception points.…
  • 2015 American Transplant Congress

    Early Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Has No Negative Impact on Patients outcome'

    B. Lowry,1 W. El Moghazy,1,2 G. Meeberg,1 N. Kneteman.1

    1Hepatobiliary Pancreatic Surgery and Transplantation, University of Alberta, Edmonton, AB, Canada; 2Surgery, Sohag University, Sohag, Egypt.

    Liver transplantation (LT) is the only therapeutic option for primary sclerosing cholangitis (PSC), however, recurrence of PSC (rPSC) post-LT occurs at rates ranging from 9-47%.…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences